Gainers
- Nymox Pharmaceutical NYMX shares moved upwards by 24.7% to $0.54 during Friday's after-market session. The company's market cap stands at $48.8 million.
- First Wave BioPharma FWBI shares increased by 23.11% to $0.8. This security traded at a volume of 1.8 million shares come close, making up 187.6% of its average volume over the last 100 days. The company's market cap stands at $4.6 million.
- Intelligent Bio Solutions INBS shares rose 23.01% to $0.31. The market value of their outstanding shares is at $5.6 million.
- Pluri PLUR stock moved upwards by 10.43% to $1.27. The company's market cap stands at $49.6 million.
- Owlet OWLT shares moved upwards by 7.71% to $0.65. The market value of their outstanding shares is at $74.2 million.
- Vallon Pharmaceuticals VLON shares increased by 6.93% to $0.29. Vallon Pharmaceuticals's trading volume hit 120.0K shares by close, accounting for 4.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.9 million.
Losers
- Minerva Surgical UTRS shares fell 6.8% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $6.8 million.
- Reshape Lifesciences RSLS shares decreased by 5.39% to $8.25. The company's market cap stands at $3.9 million.
- Achilles Therapeutics ACHL shares decreased by 5.09% to $1.12. The market value of their outstanding shares is at $45.8 million.
- Jasper Therapeutics JSPR shares fell 5.06% to $1.69. This security traded at a volume of 6.6 million shares come close, making up 372.8% of its average volume over the last 100 days. The company's market cap stands at $62.6 million.
- LogicMark LGMK shares declined by 5.0% to $0.36. The market value of their outstanding shares is at $3.4 million.
- RAPT Therapeutics RAPT stock fell 4.99% to $24.99. The market value of their outstanding shares is at $848.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in